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Malaria is one of the most life-threatening infectious diseases worldwide. Immunity to
malaria is slow and short-lived despite the repeated parasite exposure in endemic areas.
Malaria parasites have evolved refined machinery to evade the immune system based
on a range of genetic changes that include allelic variation, biomolecular exposure of
proteins, and intracellular replication. All of these features increase the probability of
survival in both mosquitoes and the vertebrate host. Plasmodium species escape from
the first immunological trap in its invertebrate vector host, the Anophelesmosquitoes. The
parasites have to pass through various immunological barriers within the mosquito such
as anti-microbial molecules and the mosquito microbiota in order to achieve successful
transmission to the vertebrate host. Within these hosts, Plasmodium species employ
various immune evasion strategies during different life cycle stages. Parasite persistence
against the vertebrate immune response depends on the balance among virulence
factors, pathology, metabolic cost of the host immune response, and the parasites
ability to evade the immune response. In this review we discuss the strategies that
Plasmodium parasites use to avoid the vertebrate host immune system and how they
promote successful infection and transmission.
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INTRODUCTION
Malaria still remains one of the biggest global health burdens and causes of mortality in the world.
Malaria mainly occurs in tropical and subtropical parts of the world, being a serious cause of
mortality and morbidity in Sub-Saharan Africa. There are five species of Plasmodium that cause
disease in humans: P. ovale, P. malariae, P. vivax, P. falciparum, and the primate species P. knowlesi.
In a previous report by the WHO, there were 215 million cases and 438 thousand deaths due to
malaria in 2015 (WHO, 2015). Malaria is transmitted by the female Anopheles mosquito during a
feeding. As the mosquito feeds on its host, sporozoites are released into the blood stream, and they
migrate to the liver (Cirimotich et al., 2010). The complete life cycle of Plasmodium requires two
hosts: the mosquito vector and the vertebrate host (Crompton et al., 2014). In the vertebrate host
it undergoes two stages: an asymptomatic pre-erythrocytic stage (liver stage), and a symptomatic
erythrocytic stage (blood stage) (Haque and Engwerda, 2014). The journey of sporozoites to the
liver is asymptomatic (Zheng et al., 2014), but various reports have described that an initial immune
response occurs during this stage. Some of the immunological responses described to occur during
the liver stage are: apoptosis of infected cells (Meslin et al., 2007), isolation and targeting of
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parasites in specific compartments for elimination (Yano and
Kurata, 2011), type I IFN production induced by parasite RNA
(Liehl et al., 2015) and LC3-mediated autophagy targeting of
sporozoites (Risco-Castillo et al., 2015). Nevertheless, several
mechanisms such as immune evasion, immune exploitation,
and molecular piracy are employed by the parasites to promote
their survival in the host (Hisaeda et al., 2005). After the first
immunological attack during liver stage, the majority of parasites
that survived will replicate within the hepatocytes and amplify
their number exponentially leading to the release of hundreds of
thousands of merozoites into circulation (Prado et al., 2015). The
released merozoites will subsequently initiate the symptomatic
blood stage cycle, which is responsible for the clinical features
and pathologies associated with malaria (Ocaña-Morgner et al.,
2003).
During the blood stage some parasites will differentiate into
male and female gametocytes. The gametocytes will be ingested
by other feeding mosquitoes where they will further develop
inside the mosquito gut (Cirimotich et al., 2010). Within the
mosquito, ineffective sporozoites will be kept until the next
blood meal, where they will be transmitted to a mammalian
host continuing the parasite life cycle (Molina-Cruz et al., 2012).
The complexity of the parasite life cycle allows for the use of
various immune evasion strategies by Plasmodium, which pose a
challenge to the development of a malaria vaccine (Hisaeda et al.,
2005). In this review, we discuss some of the immune evasion
strategies that have been described for Plasmodium at both the
liver and the blood stages. We also highlight how these immune
evasion strategies can promote successful infection, overcoming
many of the challenges that human pathogens face with the host
immune response.
IMMUNE EVASION DURING THE
PRE-ERYTROCYTIC STAGES
Mechanical Strategies to Overcome the
First Barrier: the Skin
An infected mosquito bite transmits around 100–200 sporozoites
in the human skin and despite innate immune destruction
of most of them; some parasites are still able to establish
successful infection at very low numbers (Risco-Castillo et al.,
2015). The skin is the first barrier that parasites encounter after
transmission into the vertebrate host (Cirimotich et al., 2010).
Thus, sporozoites have evolved to overcome this barrier by
various mechanical strategies such as motility and cell transversal
(Tavares et al., 2013). To achieve this, sporozoites are equipped
with specialized mechanical proteins that help them achieve
successful passage. This has been evidenced by studies that
show how the transmission of sporozoites deficient in SPECT-1
(spororozoite microneme protein essential for cell traversal) and
SPECT-2 (also called perforin-like protein 1 or PLP1) are blocked
in the dermis and are ingested by phagocytes preventing their
progression. These proteins were reported to be necessary for
cell traversal and for migration to the liver (Patarroyo et al.,
2011). The sporozoites can tranverse various kind of cells,
wich includes immune cells. The transversal of immune cells
can lead to inactivation of immune cell defenses and prevent
the clearance of sporozoites (exocytosis) before crossing the
barrier (Sinnis and Zavala, 2012). Another protein responsible
for motility of sporozoites is TRAP (Thrombospondin-Related
Anonymous Protein). This protein is found on the micronemes
and the surface of sporozoites. TRAP allows the parasite to
interact with surface host molecules that provide gliding motility
to exit the dermis. Additionally, TRAP can bind to sulfated
glycoconjugate motifs that can aid in recognition and entry
to hepatocytes (Müller et al., 1993). Regardless, some of the
sporozoites will enter the lymphatic system where they can be
recognized and destroyed by immune cells such as dendritic cells
(DCs) (Wilson et al., 2016).
Overcoming the Hepatic Immune Defenses
to Establish Liver Stage Infection
A successful infection in great part is due to the parasite evading
the first attacks of the host immune response, that despite its
strength, it is not enough to block the development of the
blood stage (Singh et al., 2010). After the sporozoites migrate
from the skin, crossing all cellular barriers, they will reach the
blood, and consequently the lymphatic system (Crompton et al.,
2014). Once inside the circulatory system, sporozoites rapidly
reach the sinusoid cavity of the liver. The exoerythrocytic (liver)
stage has been described as asymptomatic because the liver is
an immunoprivileged organ that is protected against a strong
immune response (Liehl et al., 2015). Even though initially the
liver stage was considered an unresponsive phase, various reports
have showed that the liver immune cells are present and active
in different rodent malaria models, suggesting an initial immune
response during the liver stage (Liehl et al., 2014). Some reports
have described how Plasmodium RNA could activate the type I
interferon (IFN) pathway via the cytosolic Pattern Recognition
Receptor (PRR), MDA5 (Liehl et al., 2014). Type I interferons
are potent inflammatory cytokines that are known to inhibit
growth of exoerythrocytic forms (Hisaeda et al., 2005). Some of
the cells that mediate these anti-parasitic effects include Natural
Killer and Natural Killer T cells (NK, NKT), and γδT cells.
These cells mainly inhibit parasite growth through secretion of
interferon, including both type I interferons and IFN-γ (Ocaña-
Morgner et al., 2003; Risco-Castillo et al., 2015). Other molecules
such as hepcidin have been implicated in growth inhibition of
exoerytrhrocytic phases (Spottiswoode et al., 2014).
Modulation on of Kupffer Cells
To invade hepatocytes, sporozoites must cross the barrier lined
by endothelial cells (ECs) and immune phagocytic cells called
Kupffer Cells (KCs) (Tavares et al., 2013). Sporozoites will have to
interact with these resident cells in order to establish a successful
infection (Meslin et al., 2007).
When the sporozoites reach the liver they are attracted
to sulfated molecules that are present in ECs and KCs. This
interaction is mainly mediated between the circumsporozoite
protein (CSP) and sulfated heparin sulfate proteogycans (HSPGs)
in the surface of the host cells. Other molecules that are involved
in this process include P39 and CD38 (Cha et al., 2015).
Previous studies employing intravital and electron microscopy
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suggested KCs, but not the ECs are the preferred passage used
by sporozoites (Cha et al., 2015). Recent studies proposed that
sporozoites exploit multiple paths to cross the sinusoidal barrier.
Also, there have been reports that sporozoites pass through
gaps between ECs and KCs, not engaging in traversal capacity
(Meis et al., 1983). For the sporozoites passing through KCs,
it would be interesting to know why the KCs do not degrade
parasites even though they efficiently kill other microorganisms
that invade hepatocytes (Sinnis and Zavala, 2012). Additionally,
it has been described in a mice model that sporozoites can go
through KCs and modulate their cytokine profile, leading to the
down-regulation of Th1 cytokines (TNF-α, IL-6, and MCP-1)
and the upregulation of Th2 cytokines (IL-10) for ensuring safe
passage (Klotz and Frevert, 2008). Additionally, CSP can interact
with LRP-1 (low-density lipoprotein receptor-related protein)
and proteoglycans on the KC surface, which increases the levels
of intracellular cAMP/EPAC and prevents the formation of
reactive oxygen species (ROS). ROS is a natural byproduct that
is produced during environmental stress and can cause cellular
damage and it can kill the parasite (Ikarashi et al., 2013). In
some cases, the parasite forces the KCs into apoptosis. Lastly,
sporozoites can also negatively affect the antigen-presentation
capacity of KCs, which display reduced expression of MHC-
class I and IL-12 (Steers et al., 2005). Some evidence suggests
that sporozoites are able to manipulate the KCs functions and
immunosupress the microenvironment for its own advantage.
Modulation of Hepatocytes
After successful penetration of the sinusoidal cell layer,
sporozoites enter the hepatocytes and start intra-hepatic
development. Sporozoites actively invade the host cells
(hepatocytes) employing the cholesterol uptake pathway, which
is different from other microorganisms that exploit phagocytic
activity of host cells for invasion (Itoe et al., 2014). Additionally,
released CSP supports parasite development through the
suppression of the NF-κB signaling pathway (Ding et al., 2012)
and the up regulation of host heme oxygenase-1 (HO-1), which
further promotes the parasite development in the liver by
modulating the host inflammatory response (Pamplona et al.,
2007). Sporozoite infection of hepatocytes also interferes with
the mTOR pathway, which alters the levels of proteins involved
in cell survival, proliferation, autophagy, anabolism, and cell
growth (Hanson et al., 2013). After invading the final hepatocyte,
sporozoites are enclosed in a parasitophorous vacuole (PVM),
which physically separates it from the host cytoplasm thereby
avoiding degradation by the endocytic/lysosome system. This
isolation keeps the parasitophorous vacuole isolated from cell
intrinsic defenses such as apoptosis and selective autophagy
(Thieleke-Matos et al., 2016). The transition of parasites from
liver stage merozoites to initiate blood stage represents another
key point of the cycle for immune evasion. In order to start the
blood stage, liver stage parasites must exit from the hepatocytes
through hepatic spaces where they are exposed to resident
phagocytic cells such as KCs and DCs. Merozoites avoid being
killed by liver phagocytes by covering themselves in membranes
derived from the host known as merosomes (Sturm et al., 2006).
The merosomes are derived from infected hepatocytes when
they bud off from the cells and manage to avoid recognition
by phagocytes to initiate blood stage (Garg et al., 2013). The
initiation of blood stage could take days after exiting the liver.
Collectively, all of this data demonstrates the long journey that
parasites travel to overcome the immune system.
IMMUNE EVASION BY ERYTHROCYTIC
PARASITE STAGES
The blood stage is where the clinical symptoms that are
characteristic of malaria appear. Blood stage is initiated
when merozoites released from hepatocytes invade RBCs to
develop into ring shaped, and young and mature trophozoites,
undergoing schizogony. In schizogony each one leads to six
to 32 daughter clones that will burst out into the bloodstream
and reinvade new RBCs (Garg et al., 2013). An effective anti-
parasitic immunity has been proven to be complex and involving
various elements of the immune system. Antibodies and T-
cells have proven to be important components in achieving
parasite clearance (Chotivanich et al., 2002). Antibodies can
have anti-parasitic activity by binding to infected erythrocytes
and mediating their phagocytosis (opsonization) by circulating
macrophages (Dups et al., 2014). They can also prevent invasion
of red blood cells by binding to extracellular merozoites and
marking them for clearance or lysis by complement. T-cells
play an essential role by both direct and indirect mechanisms.
Direct mechanisms include production of pro-inflammatory
cytokines such as IFN-γ and TNF-α that prime macrophages
and other components of the anti-parasite immune response
(Nasr et al., 2014). They also mediate an indirect mechanism by
activating specific B-cell clones that will produce anti-parasite
antibodies (Kafuye-Mlwilo et al., 2012). Other innate immune
components that have been attributed to play a role include: NK
cells, γδT cells (Inoue et al., 2013), host microbiota and natural
antibodies (Crompton et al., 2014). Circulating infected blood
cells can be targeted for destruction in the spleen but the parasite
avoids this by developing several mechanisms to evade the host
immune response (Chotivanich et al., 2002). As an example for
complement evasion, inhibition of the membrane attack complex
(MAC) formation has been described in P. falciparum-infected
patients and it even correlated with severe malaria cases (Schmidt
et al., 2015).
The intracellular survival is themost primitive immune escape
mechanism of parasites, which avoid the direct interaction of
parasites with the immune cells. Furthermore, RBCs do not
express MHC class I molecules on their surface thereby escaping
from recognition by CD8+ T cells (Bowen and Walker, 2005).
Another feature that parasites use to avoid clearance is the
formation of rosettes. Rossettes is a phenomenon where infected
erythrocytes cluster with uninfected erythrocytes helping the
parasites bind to RBC epitopes and avoid immune recognition.
Blood type is one factor correlated with the rosette formation. For
example parasites that bind blood type A are more virulent than
the ones that bind blood type O because their capacity of forming
rosettes is stronger (Moll et al., 2015).
Overall the evasion mechanisms are divided in two fields of
strategies. One of them is the expression of variable antigenic
proteins at the surface in different life cycle stages of parasites
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that help camouflage them from the host immune system
(Escalante et al., 1998). The evasion of immune clearance is
due the highly polymorphic proteins that mediate antigenic
variation by changing and adapting to host immune response,
promoting long-lasting infections (Wilson et al., 2016). The
second is sequestration, which is mediated by genes products of
the PfEMP-1, Var, Rifin (Mwakalinga et al., 2012), and Stevor
multigene families (Kraemer and Smith, 2006). These proteins
allow iRBC adherence in vascular endothelium hence avoiding
clearance, and sequestering them in the microvasculature of
various organs. They also exploit host components such as
platelets and inflammation that can lead agglutination of
uninfected RBCs with iRBCs and promote the appropriate
sequestration microenvironment (Helmby et al., 1993).
In the blood stream, merozoites utilize complex set of proteins
in order to invade uninfected red blood cells (Helmby et al.,
1993). The parasite locates closely its proteins to proteins of
the host erythrocytes, mediating reorientation and tight binding
allowing them to invade the host RBCs. MSP-1 (merozoite
surface proteins) anchors in the host erythrocyte membrane
through GPI (glicosilfosfatilinositol) anchors. (Nosjean et al.,
1997). MSPs along with other merozoite proteins called
erythrocyte binding-like (EBL) proteins exist in several alleles or
copies in the genome, showing a high degree of polymorphism
(Holder et al., 1999). Several studies about new vaccine
candidates against malaria are based in interactions between
surface proteins, such as MSPs, GPI and PfEMP-1 (Boyle et al.,
2014). The EBL protein family has a sophisticated profile with
redundant functions that evolved to promote antigenic variation
and immune evasion (Souza-Silva et al., 2014). EBL proteins are
proteins that contain a Duffy-binding-like (DBL) which have
been shown to mediate host receptor binding, in the case of
P.vivax infection (VanBuskirk et al., 2004).
All Plasmodium species use to the same principle for invasion
of the cell through interaction of parasite proteins to host
erythrocyte receptor. The most studied invasion mechanisms
are the ones used by P.vivax and P.falciparum. The merozoites
of P.falciparum have at least five mechanisms of invasion,
characterized by its respective receptor in erythrocytes (Baum
et al., 2003). P.vivax shows great preference to invade immature
red blood cell forms, such as reticulocytes. Some studies have
reported that people who have the DARC (Duffy antigen receptor
chemokines) in erythrocytes are more susceptible to infection
by P. vivax. Conversely, the lack of this receptor (Souza-Silva
et al., 2014) confers resistance to infection by P. vivax. However,
other studies from west Kenya and Brazil have reported P.vivax
cases, despite the lack of DARC expression in RBCs, suggesting
alternative pathways for P.vivax infection (Ryan et al., 2006).
P. falciparum has evolved more adapt ways of immune
evasion. One of the most studied strategies is the exposure
PfEMP1 on infected red blood cells. The PfEMP-1 expression is a
sophisticated apparatus that promotes the ability to bind different
host endothelial cells, such as human brain microvascular
endothelial cells (HBMEC). This binding helps the parasites
avoid clearance by the spleen and it‘s directly related to
complicated falciparum malaria such as cerebral malaria (Abdi
et al., 2016).
The alterations in the iRBC membrane created by exposure
of these proteins are denominated Knobs. These knobs will
mediate cytoadhesion to the endothelium. Some of the targeted
endothelium receptors include EPCR, CSA, CD36, and ICAMs
(Yipp et al., 2000). Condroitin sulfate A (CSA) is the receptor
targeted by the specific variant that leads to placental malaria
in pregnant women (Kraemer and Smith, 2006). Each PfEMP
variant can promote binding to different receptors in several
organs (Hviid and Jensen, 2015). In both iRBC and uninfected
RBCs in severe malaria, the erythrocytes become rigid following
impediment to their flow through capillaries that have midpoint
diameters that are all smaller than the erythrocyte itself (Dondorp
et al., 2000). This can block parasite recirculation or recruitment
of non-infected RBCs leading to rosettes (Uyoga et al., 2012)
and has been associated with severe malaria anemia (Uyoga
et al., 2012). Knobs sequestration in post-capillary venules
occurs in mature blood stages such trophozoite and schizonts
(Sharma, 1991). The presence of the parasite leads to activation
of the immune response and production of cytokines, enhancing
expression of receptors in endothelial cells targeted by the
parasite adhesins (Rowe et al., 2009). This promotes the cyclical
fevers associated with malaria while the constant presence
of parasite exacerbates the inflammatory immune response
(Gazzinelli et al., 2014).
Inadequate Innate and Adaptive
Responses against Plasmodium Blood
Stage Parasites
Even though the parasite has evolved various immune evasion
strategies, the host immune response along with its genetic
background, are essential for parasite control and prevention
of clinical malaria. The human immune system is equipped
with both innate and adaptive responses with great anti-parasitic
activity. One major component of the innate immune system are
Patter Recognition Receptors (PRRs) that recognize Pathogen-
associated molecular patterns (PAMPs). In the case of malaria,
three PAMPs that have been proposed for Plasmodium parasites
are: GPI anchors, Hemozoin and immunostimulatory nucleic
acid motifs (Gazzinelli et al., 2014).
Release array of pro and anti-inflammatory can result in
either successful parasite control or alternatively an exacerbated
immune response leading to pathology (Perkins et al., 2011).
Even though mounting a potent immune response is not always
completely efficient, it is necessary for controlling parasitemia.
An important “bridge” between the innate and adaptive immune
response are the dendritic cells (DCs). The DCs have a function
of antigen presentation, stimulation of T-cells, and are major
mediators of the adaptive immune response (Gowda et al., 2012).
During malaria, CD4+ T− helper cells have been implicated
for pathogenesis, protection and immune evasion of parasites
(Wykes et al., 2014). The role of regulatory T cells (expressing
FOXP3 CD4+ CD25+) in immunity has been controversial. For
example, lack of T-regs during experimental cerebral malaria
mice models renders them more susceptible to disease; while
in human cerebral malaria correlates with higher parasitemia
(Walther et al., 2005).
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The role of CD8+ T cells-mediated immunity in blood stage
has been less studied. This is mainly due to the fact that iRBCs
don’t express MHC class I rendering them resistant to the
cytotoxic effect of CD8+ T-cells. Additionally, the high-level of
mutations of epitopes in blood stage lead to immune evasion
of the cytotoxic T lymphocyte (CTL) response, and hence fail
to generate highly effective malaria vaccines (Templeton, 2009).
Regardless, experiments using depletion both CD8+ and CD4+
T-cells during blood stage of P.chabaudi infections in mice
resulted in a delayed clearance of the infection (Podoba and
Stevenson, 1991), suggesting a possible role for CD8+ T-cells
during blood stage malaria.
B cells have been attributed to an essential protective role
during malaria. Antibody responses as immune agents alone
can provide sufficient protection to control clinical disease
(Wykes et al., 2014). The functions of antibodies can act on
limiting the growth of blood stage parasites and the development
of clinical symptoms for several mechanisms, like blocking
erythrocyte invasion (Blackman et al., 1990), act as opsonins on
parasitized erythrocytes (Osier et al., 2014), monocyte-mediated
antibody-dependent cellular killing (Bouharoun-Tayoun et al.,
1995), and complement-mediated lysis (Boyle et al., 2015), as
well as interfering with the adherence of infected erythrocytes
to vascular endothelium (Beeson et al., 2004). Unfortunately,
the antibody responses to malaria infection from children and
adults have been reported to be short-lived and rapidly lost in
the absence of continued parasite exposure (Ryg-Cornejo et al.,
2016). Collectively, these findings demonstrate that the immune
system is efficient at reducing parasite burden but in most cases
is not enough to prevent the progress of disease showing the high
capacity of immune evasion by the parasite.
CONCLUDING REMARKS
Plasmodium has evolved a range of biomolecular strategies
in order to escape the immune response and to guarantee
the survival within the host. These parasites have great
immune evasion ability across their whole life cycle. From an
asymptomatic liver stage to a sophisticated system of proteins
(such as PfEMP proteins) that is utilized by the parasite to avoid
immune recognition and establish a successful infection. Hence
further studies requiring close interactions of biomolecular,
genetic, and immune strategies in both host and parasites
are needed in order to understand better a protective anti-
Plasmodium immunity. Thereby, in this review we summarize
some of the important mechanisms that Plasmodium parasites
utilize to facilitate evasion of the vertebrate host immune
system across its life cycle. The challenges for the development
of more effective therapeutics will have to overcome the
various parasite immune evasion strategies and as several
species cause malaria, several antigenic variations have to be
considered. Recently we have a good candidate malaria vaccine
in phase III (RST,S - GSK) of implanting, but even with a
good initial response, it was also proved to be incomplete in
points of recurrence of the disease (Morrison, 2015). Thus,
the well-studied avoidance schemes propose an opening of
new possibilities for further studies to consolidate the burden
that malaria causes to hundreds of thousands of people
annually.
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